CLIENT CHALLENGE

Help a “start-up” within a Fortune 200 CPG and healthcare company develop the brand, positioning, architecture and communication materials needed to bring its revolutionary drug-delivery system to market in the $141 billion biologic drug category*.

HUMAN-CENTRIC MISSION

Eliminate the pain, anxiety and other drawbacks of injections in order to help patients enjoy a better quality of life.

OUR APPROACH

• Crystallize and quantitatively vet a winning proposition relevant to three distinct audiences—patients, physicians and payers.
• Create brand foundational tools and a trademarked global naming system for the new brand and the product’s unique features.
• Build a selling story and marketing materials to excite internal leadership and attract potential pharmaceutical partners.

THE OUTCOME

Seed created a brand identity and selling strategy that showcased the technology’s huge potential, attracting the interest of a large biopharmaceutical company that ultimately purchased the brand.

Source: https://www.statista.com/statistics/947455/global-subcutaneous-biologics-market/

Learn more about Seed Strategy’s innovation solution!

Designed by brand strategists, researchers, creatives, data scientists, and behavioral experts, our solution empowers innovation teams to accelerate growth, build brand strength, and drive stronger ROI through deep consumer understanding and tailored AI.

Connect with us! Follow Seed Strategy on LinkedIn for the latest from our team.